Yahoo奇摩 網頁搜尋

搜尋結果

1. www.cna.com.tw › news › ahelNovavax疫苗來了 哪些人適合打、保護力如何QA一次看 | 生活 | 中 ...

   www.cna.com.tw › news › ahel

   • 庫存頁面

   2022年3月25日 · 中央流行疫情指揮中心指揮官陳時中證實200多萬劑Novavax疫苗將陸續抵台，有機會成為國內第5款獲准施打的COVID-19疫苗。究竟這款已獲世衛核准緊急 ...

2. www.who.int › news-room › feature-storiesThe Novavax vaccine against COVID-19: What you need to know ...

   www.who.int › news-room › feature-stories

   • 庫存頁面

   2022年9月28日 · The Novavax vaccine will be manufactured in two different facilities. In Europe, the vaccine will be manufactured under the trade name Nuvaxovid and has been approved by the European Medicines Agency, and in India, the vaccine will be manufactured by Serum Institute of India under the trade name Covovax and has been approved by the Drugs Controller General of India.

3. www.nature.com › articles › d41586/021/00268-9Novavax offers first evidence that COVID vaccines protect ...

   www.nature.com › articles › d41586/021/00268-9

   • 庫存頁面

   2021年1月29日 · Novavax’s experimental shot is highly effective against the variant identified in Britain — but saw a worrying drop in efficacy against a lineage detected in South Africa.

4. www.cdc.gov.tw › Uploads › 5ef2eed0/0043/4c23-91f9-0dc3b747fbcNovavax (Nuvaxovid) COVID-19 疫苗接種須知 - 衛生福利部疾病管 ...

   www.cdc.gov.tw › Uploads › 5ef2eed0/0043/4c23-91f9-0dc3b747fbc

   6. 接種Novavax COVID-19疫苗後有罕見心肌炎或心包膜炎不良事件的通報案件，歐盟與澳洲於 Novavax疫苗上市後持續監測罕見心肌炎或心包膜炎之不良事件。目前Novavax疫苗接種與心 肌炎或心包膜炎之間，尚未確定是否有因果關係2~4。Novavax (Nuvaxovid

5. ir.novavax.com › press-releases › 2023/08/22-Novavaxs-UpdatedNovavax's Updated Protein-based XBB COVID Vaccine ...

   ir.novavax.com › press-releases › 2023/08/22-Novavaxs-Updated

   • 庫存頁面

   2023年8月22日 · Novavax's 2023-2024 season COVID vaccine candidate induced neutralizing responses to emerging subvariants EG.5.1 and XBB.1.16.6 in addition to XBB.1.5, XBB.1.16 and XBB.2.3You have selected a link that will take you to a site maintained by a third party.

6. www.nejm.org › doi › fullSafety and Efficacy of NVX-CoV2373 Covid-19 Vaccine | NEJM

   www.nejm.org › doi › full

   2021年6月30日 · Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), which consists of 5 μg of a recombinant nanoparticle spike protein plus 50 μg of Matrix-M adjuvant, have shown that a two ...

7. www.bnext.com.tw › article › 70752【觀點】Novavax的新冠疫苗來了！優勢、免疫效果、副作用、接種 ...

   www.bnext.com.tw › article › 70752

   • 庫存頁面

   2022年7月23日 · Novavax 的新冠肺炎疫苗有什麼優勢？ 這並不是人類第一次使用次單位蛋白疫苗，過去像是子宮頸癌疫苗、B 肝疫苗也都使用類似的技術。Novavax 的次單位蛋白疫苗可以在 2-8 下保存，相較既有的 mRNA 疫苗需要全程維持在低溫冷鏈下運輸，更具優勢。